Laboratorios Microsules Uruguay S.A.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Chemical Manufacturing Available in: English & Spanish Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about Laboratorios Microsules Uruguay S.A. from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Ruta 101, Km.28, Cno. al Paso Escobar S/N
Canelones; Canelones; Map
Postal Code: 91100

Tel: +598-2-288-
Fax: +598-2-288-



Company Description
Laboratorios Microsules Uruguay was established in the local and international market some 30 years ago. Its main activities are related to manufacturing, synthesizing, marketing and distributing veterinary medicines as well as a growing line of agricultural products. It also develops and manufactures a complete line of household aerosols and an extensive portfolio of insecticides. It offers more than 20 product lines involving about 1800 articles in the global market for 14 animal species and has a state-of-the-art experimental field with animal welfare certification to perform its own tests. Laboratorios Microsules has developed a successful export profile, permanently expanding in foerign markets. It currently has subsidiaries in Brazil, Argentina, Chile, Ecuador, Mexico and Paraguay, and more than 90 distributors around the world. The company exports to more than 40 countries in Central America, South America, Africa, the Middle East and Asia, which makes it the largest exporter of veterinary products in Uruguay.
NAICS Industry Classification
Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Key Executives
General Manager
Key Financial Highlights
2016 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
Net Profit (Loss) for the Period
Total assets 48,428
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: AIN - Internal Audit Office, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.


To view more information, REQUEST A DEMO